595 related articles for article (PubMed ID: 27174990)
21. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
Caeiro LD; Nakata Y; Borges RL; Zha M; Garcia-Martinez L; Bañuelos CP; Stransky S; Liu T; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar Benitah S; Cimmino L; Bilbao D; Sidoli S; Wang Z; Verdun RE; Morey L
Genes Dev; 2024 Feb; 38(1-2):46-69. PubMed ID: 38286657
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
[TBL] [Abstract][Full Text] [Related]
23. Gene of the month: H3F3A and H3F3B.
Aldera AP; Govender D
J Clin Pathol; 2022 Jan; 75(1):1-4. PubMed ID: 34782425
[No Abstract] [Full Text] [Related]
24. Histone H3K36I mutation in a metastatic histiocytic tumor of the skull and response to sarcoma chemotherapy.
Snuderl M; Dolgalev I; Heguy A; Walsh MF; Benayed R; Jungbluth AA; Ladanyi M; Karajannis MA
Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645348
[TBL] [Abstract][Full Text] [Related]
25. Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae.
Briggs SD; Bryk M; Strahl BD; Cheung WL; Davie JK; Dent SY; Winston F; Allis CD
Genes Dev; 2001 Dec; 15(24):3286-95. PubMed ID: 11751634
[TBL] [Abstract][Full Text] [Related]
26. Dimethylation of histone H3 at lysine 36 demarcates regulatory and nonregulatory chromatin genome-wide.
Rao B; Shibata Y; Strahl BD; Lieb JD
Mol Cell Biol; 2005 Nov; 25(21):9447-59. PubMed ID: 16227595
[TBL] [Abstract][Full Text] [Related]
27. Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic intervention.
Shen C; Vakoc CR
Curr Opin Oncol; 2015 Jan; 27(1):57-63. PubMed ID: 25402979
[TBL] [Abstract][Full Text] [Related]
28. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
29. Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells.
Sankaran SM; Gozani O
Epigenetics; 2017; 12(11):917-922. PubMed ID: 28933651
[TBL] [Abstract][Full Text] [Related]
30. Histone H3 modifications associated with differentiation and long-term culture of mesenchymal adipose stem cells.
Noer A; Lindeman LC; Collas P
Stem Cells Dev; 2009 Jun; 18(5):725-36. PubMed ID: 18771397
[TBL] [Abstract][Full Text] [Related]
31. Histone H3 K36 methylation is mediated by a trans-histone methylation pathway involving an interaction between Set2 and histone H4.
Du HN; Fingerman IM; Briggs SD
Genes Dev; 2008 Oct; 22(20):2786-98. PubMed ID: 18923077
[TBL] [Abstract][Full Text] [Related]
32. Methylation of histone H3 lysine 36 is required for normal development in Neurospora crassa.
Adhvaryu KK; Morris SA; Strahl BD; Selker EU
Eukaryot Cell; 2005 Aug; 4(8):1455-64. PubMed ID: 16087750
[TBL] [Abstract][Full Text] [Related]
33. H3K27M in Gliomas Causes a One-Step Decrease in H3K27 Methylation and Reduced Spreading within the Constraints of H3K36 Methylation.
Harutyunyan AS; Chen H; Lu T; Horth C; Nikbakht H; Krug B; Russo C; Bareke E; Marchione DM; Coradin M; Garcia BA; Jabado N; Majewski J
Cell Rep; 2020 Nov; 33(7):108390. PubMed ID: 33207202
[TBL] [Abstract][Full Text] [Related]
34. Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.
Venneker S; Szuhai K; Hogendoorn PCW; Bovée JVMG
Virchows Arch; 2020 Jan; 476(1):135-146. PubMed ID: 31728625
[TBL] [Abstract][Full Text] [Related]
35. Effects of H3.3G34V mutation on genomic H3K36 and H3K27 methylation patterns in isogenic pediatric glioma cells.
Huang TY; Piunti A; Qi J; Morgan M; Bartom E; Shilatifard A; Saratsis AM
Acta Neuropathol Commun; 2020 Dec; 8(1):219. PubMed ID: 33287886
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma.
Papke DJ; Hung YP; Schaefer IM; Bredella MA; Charville GW; Reith JD; Fletcher CDM; Nielsen GP; Hornick JL
Mod Pathol; 2020 Nov; 33(11):2295-2306. PubMed ID: 32601382
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous mutation of methylated lysine residues in histone H3 causes enhanced gene silencing, cell cycle defects, and cell lethality in Saccharomyces cerevisiae.
Jin Y; Rodriguez AM; Stanton JD; Kitazono AA; Wyrick JJ
Mol Cell Biol; 2007 Oct; 27(19):6832-41. PubMed ID: 17664279
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of a histone methyltransferase by mutations in human cancers.
Kim KC; Geng L; Huang S
Cancer Res; 2003 Nov; 63(22):7619-23. PubMed ID: 14633678
[TBL] [Abstract][Full Text] [Related]
39. Distribution and maintenance of histone H3 lysine 36 trimethylation in transcribed locus.
Sein H; Värv S; Kristjuhan A
PLoS One; 2015; 10(3):e0120200. PubMed ID: 25774516
[TBL] [Abstract][Full Text] [Related]
40. A Saccharomyces cerevisiae model and screen to define the functional consequences of oncogenic histone missense mutations.
Lemon LD; Kannan S; Mo KW; Adams M; Choi HG; Gulka AOD; Withers ES; Nurelegne HT; Gomez V; Ambrocio RE; Tumminkatti R; Lee RS; Wan M; Fasken MB; Spangle JM; Corbett AH
G3 (Bethesda); 2022 Jul; 12(7):. PubMed ID: 35567477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
